Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 4Phase 2/3 3Phase 1 2Phase NA 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 3Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Solid Carcinoma 1Neoplasms 1Neoplasm Metastasis 1Malignant Ascites 1Lung Neoplasms 1Glioma 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Breast Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy, Digestive System 3Endoscopy 3Radiotherapy 2Biopsy 2chlorhexidine gluconate 1Specimen Handling 1Risk Assessment 1Radiation 1Nivolumab 1Mass Screening 1Magnetic Resonance Spectroscopy 1Immune Checkpoint Inhibitors 1High-Throughput Screening Assays 1High-Intensity Interval Training 1Hematologic Tests 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Fecal Microbiota Transplantation 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Endoscopic Mucosal Resection 1Drug Therapy 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Adenocarcinoma Of Esophagus × Nivolumab × Clear all
NCT05001360 2021-10-27

Study of FMT Combined With Nivolumab in Gastric Cancer

Fujian Cancer Hospital

Phase NA Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡